The rising interest in GLP-1 agonists for diabetes has generated a debate about delivery methods : skin-applied devices versus tablets . Usually , GLP-1 therapies were solely available in pill form, but https://poppygzql887361.blogprodesign.com/62334038/glp-1-transdermal-delivery-systems-vs-tablets-is-right-for-you